SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001599298-22-000065
Filing Date
2022-06-24
Accepted
2022-06-24 17:12:36
Documents
5
Period of Report
2022-07-27

Document Format Files

Seq Description Document Type Size
1 PRE 14A summit-specialmeetingproxy.htm PRE 14A 271658
2 PROXY CARD 1 screenshot2022-06x24164948a.jpg GRAPHIC 128736
3 PROXY CARD 2 screenshot2022-06x24165436a.jpg GRAPHIC 126546
4 PROXY CARD 3 screenshot2022-06x24165538a.jpg GRAPHIC 21506
5 PROXY CARD 4 screenshot2022-06x24165626a.jpg GRAPHIC 153540
  Complete submission text file 0001599298-22-000065.txt   866189
Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 617-514-7149
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36866 | Film No.: 221040895
SIC: 2834 Pharmaceutical Preparations